Page 1364 - TNFlipTest
P. 1364

 U46 Urology
References
Toronto Notes 2019
 References
General Information
American Urological Association. Available from: http://www.auanet.org/guidelines/.
Canadian Urological Association. Available from: http://www.cua.org/guidelines_e.asp.
Ferri F. Practical guide to the care of the medical patient, 6th ed. St. Louis: Mosby, 2006.
Goldman L, Ausiello D. Cecil textbook of medicine, 23rd ed. Philadelphia: WB Saunders, 2007.
Macfarlane MT. House officer series: urology, 3rd ed. Philadelphia: Lippincott, 2001.
Montague DK, Jarow J, Broderick GA, et al. Guideline on the management of priapism. American Urological Association Education and Research, Inc. ©2003. Available from: http://www.auanet.org/education/guidelines/priapism.cfm. Tanagho EA, McAninch JW. Smith’s general urology, 17th ed. New York: McGraw-Hill, 2007.
Wein AJ, Kavoussi LR, Novick AC, et al. Campbell’s urology, 10th ed. Philadelphia: WB Saunders, 2011. Wieder JA. Pocket guide to urology, 4th ed. Oakland: Wieder, 2010.
Common Presenting Problems
Bettez M, Tu LM, Carlson K, et al. 2012 Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association. CUAJ. 2012;6(5):354-363. Bremnor JD, Sadovsky R. Evaluation of dysuria in adults. Am Fam Phys 2002;65:1589-1597.
Cohen RA, Brown RS. Microscopic hematuria. NEJM 2003;348:2330-2338.
Cox A, Golda N, Nadeau G, et al. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. CUAJ. 2016;10:E136-E155.
Kassouf W, Traboulsi SL, Kulkarni GS, et al. CUA guidelines on the management of non-muscle invasive bladder cancer. CUAJ. 2015;9:E690-E704.
Morton AR, Iliescu EA, Wilson JWL. Nephrology: investigation and treatment of recurrent kidney stones. CMAJ 2002;166:213-218.
Nickel JC. Prostatitis. CUAJ. 2011;5:306-315.
Rendon RA, Mason RJ, Marzouk K, et al. Canadian Urological Association recommendations on prostate cancer screening and early diagnosis. CUAJ. 2017;11:298-309. Teichman JMH. Acute renal colic from ureteral calculus. NEJM 2004;350:684-693.
Overactive Bladder
Ouslander JG. Management of overactive bladder. NEJM 2004; 250:786-799.
Benign Renal Neoplasm
Israel GM, Bosniak MA. An update of Bosniak renal cyst classification system, Urology 2005;66:484-488.
Richard PO, Violette PD, Jewett MAS, et al. CUA guideline on the management of cystic renal lesions. CUAJ. 2017;11:E66-E73.
Urological Emergencies
Galejs LE. Diagnosis and treatment of the acute scrotum. Am Fam Phys 1999;5:817-824.
Medications
Bill-Axelson A, Holmberg L, Ruutu M, et al. SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. NEJM 2011;364:1708-1717.
Compendium of Pharmaceuticals and Specialties. Available from: http://www.e-therapeutics.ca.
Micromedex health care series. Available from: http://www.micromedex.com.
Rini B, Halabi S, Rosenberg J, et. al. Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 trial. J Clin Oncol 2008;26:5422-5428.
EBM
Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. NEJM 2011;364:1708-1717.
Campschroer T, Zhu Y, Duijvesz D, et al. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane DB Syst Rev 2014;4:CD008509.
Coelho RF, Rocco B, Patel MB, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 2010;24:2003-2015.
Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. NEJM 2007;356:125-134.
Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. NEJM 2003;349:859-866.
Hoffman RM, Monga M, Elliott SP, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane DB Syst Rev 2012;9:CD004135.
Ilic D, O’Connor D, Green S, et al. Screening for prostate cancer. Cochrane DB Syst Rev 2013;1:CD004720.
James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. NEJM 2012;366:1477-1488.
Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998;159:425-427.
McDonnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. NEJM 2003;349:2387-2398.
Millett GA, Flores SA, Marks G, et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008;300:1674-1684.
Motzer RJ, Escudier B, Tomczak P, et al. Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomized phase 3 trial. Lancet Oncol 2013;14:552-562. Parsons JK, Hergan LA, Sakamoto K, et al. Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol 2007;177:983-987.
Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. NEJM 2009;360:1320-1328.
Siegfried N, Muller M, Deeks JJ, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane DB Syst Rev 2009;2:CD003362.
Tacklind J, Fink HA, Macdonald R, et al. Finasteride for benign prostatic hyperplasia. Cochrane DB Syst Rev 2010;10:CD006015.
Wiesenthal JD, Ghiculete D, D’A Honey RJ, et al. A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent? J Endourol 2011;25:481-485.
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. NEJM 2012;367:203-213.

















































   1362   1363   1364   1365   1366